CD19 and systemic sclerosis: First, to determine the number of topo I-reactive CD27+ B cells in SSc patients, frequencies of topo I-APC+ topo I-PE+ CD27+ CD19+ cells in the peripheral blood were examined with flow cytometric analysis.